Genomic micro-array and whole exome sequencing
Genomic micro-array and whole exome sequencing (WES) tests may identify, or confirm the presence of chromosome abnormalities.
Status: Decision completed
Why are genomic micro-array and WES being reviewed?
Whether results from genetic sequencing can improve diagnosis, treatment decisions, and health outcomes in some situations remains uncertain.
Primary criteria ranking
- Safety = Medium
- Efficacy = High
- Cost = High
Documentation
| Type | Materials |
|---|---|
| Assessment (2017) |
Assessment timeline
- Draft key questions published: August 16, 2017
- Public comment period: August 16 to August 29, 2017
- Final key questions published: September 14, 2017
- Draft report published: November 9, 2017
- Public comment period: November 9 to December 8, 2017
- Final report published: December 22, 2017
- HTCC public meeting: January 19, 2018